Skip to content
Screener

Evolent Health, Inc. EVH Reportable segment — Other segment items

Similar metrics at other companies

Broadridge Financial Solutions logo
BRTotal Reportable Segments — Other segment items
$121.4M+7.5%
Iron Mountain logo
IRMTOTAL REPORTABLE SEGMENTS — Other segment items
$938.34M+13.0%
GLW
GLWTotal Reportable Segments — Other segment items
$2.77B+16.4%
CNN
CNNETotal Reportable Segments — Other segment items
$52.3M+403%
RCI Hospitality Holdings logo
RICKReportable Segments Excluding Other — Other segment items
$0-100%
Veradermics logo
MANEReportable Segment — Other segment items
-$2.63M-411%

Other financials

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%
EPS (diluted)-$0.25+43.2%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation

See full
Market cap$446.58M-58.2%
Enterprise value$1.3B-26.5%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept evh:OtherSegmentItems.

The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:53 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628908-26-000086
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Selling, general and administrative expenses excluding other segment items (3)53,48163,888115,707130,156
Depreciation and amortization expenses21,56623,14143,12147,199
Interest income(703)(1,084)(1,717)(2,358)
Interest expense16,85911,60133,72721,986
Gain (loss) from equity method investees41(197)52(178)
Provision for (benefit from) income taxes2,715(825)3,625645
Other segment items (4)15,93656,00126,305130,453
Net loss attributable to common shareholders of Evolent Health, Inc.$(28,364)$(51,090)$(54,996)$(123,340)

Item 1. Financial Statements

FAQ

What is Evolent Health, Inc.'s reportable segment — other segment items?
Evolent Health, Inc. (EVH) reported reportable segment — other segment items of $15.94M in Q2 2026.
How has Evolent Health, Inc.'s reportable segment — other segment items changed year-over-year?
Evolent Health, Inc.'s reportable segment — other segment items decreased by 71.5% year-over-year, from $56M to $15.94M.
What is the long-term trend for Evolent Health, Inc.'s reportable segment — other segment items?
Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — other segment items has grown at a 52.4% compound annual growth rate (CAGR), from $46.09M to $163.11M.
What does reportable segment — other segment items mean?
This category includes miscellaneous income or expenses that are specific to the segment but fall outside of core operating activities. It is used to capture non-recurring or unique financial events that impact the segment's reported performance.

Ask your AI about Evolent Health, Inc.'s reportable segment — other segment items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude